Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$6.87 -0.72 (-9.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Gains from Investment Securities (2023 - 2024)

Updated

Analysis

Eupraxia Pharmaceuticals (EPRX) Gains from Investment Securities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Eupraxia Pharmaceuticals 274.50 Mn -169.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -430,499.00
Mar 31, 2024 -770,042.00
Dec 31, 2023 -1.25 Mn
Sep 30, 2023 -1.88 Mn
Jun 30, 2023 3.65 Mn
Mar 31, 2023 314,080.00
API Access

Eupraxia Pharmaceuticals Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=EPRX&period=max&api_key=YOUR_API_KEY